668 Views

Instructional Course

Instructional Course - Available with the Platinum and Silver packages or Individual Course Ticket

054IC - Prostate Cancer Diagnostics: Biomarkers, MRI and Biopsy Techniques

Sunday, May 15, 2022

10:00 AM – 12:00 PM

Location: Room 207

Instructional Course Director(s)

DB

Daniel Ari Barocas, Dr.

Professor of Urology
Vanderbilt University Medical Center

Instructional Course Faculty(s)

John Thomas Wei, MD

Professor
University of Michigan
Scott E. Eggener, MD

University of Chicago
SC

Sigrid Viktoria Carlsson, MD, PhD, MPH

Assistant Attending Epidemiologist
Memorial Sloan Kettering Cancer Center

Learning Objectives:

Explain how to maximize the benefits and minimize the harms of prostate cancer detection by carefully selecting patients and by using the necessary tools to detect clinically meaningful prostate cancer while avoiding unnecessary biopsies and detection of clinically unimportant cancers.
Identify the evidence supporting the use of PSA for early detection of prostate cancer and apply that evidence to different clinical scenarios, incorporating patient characteristics and preferences.
Discuss the available blood, urine and tissue biomarkers used to enhance detection of higher-grade prostate cancer, the evidence supporting their use and the clinical scenarios in which they are most valuable to be used.
Use MRI and fusion biopsy to enhance the detection of clinically significant prostate cancer.
Employ safe biopsy practices with respect to approach, avoidance of infection and attention to patient comfort.
Explain the rationale for transperineal prostate biopsy and its technique
Be able to establish a transperineal biopsy practice.

Prostate cancer detection remains one of the most common and most controversial aspects of urologic practice. In addition to the complexities around screening and use of prostate specific antigen (PSA), the role of other biomarkers, biopsy techniques such as transperineal biopsy and magnetic resonance imaging (MRI) for targeted biopsy are evolving rapidly. This course is intended for urologists, advanced practice providers and trainees interested in using the most evidence-based methods for optimizing detection of clinically important prostate cancers, while improving patient experience and minimizing complications. The attendee will explore the continuing controversy of screening for prostate cancer, prostate cancer detection guidelines, use of PSA, PSA adjuncts and isoforms, and other blood, urine and tissue-based biomarkers for prostate cancer detection. This will lead into a discussion of prostate biopsy, including concepts crucial to reducing morbidity of prostate biopsy and improving patient experience. This course reviews available data regarding biopsy indications and techniques, including a strong emphasis on transperineal prostate biopsy. Additionally, this course fully explores the imperative of having a purposeful approach to biopsy aimed at diagnosing clinically meaningful cancer while minimizing detection of clinically insignificant cancer. We also present the most current information regarding the use of image guided biopsy techniques, such as MRI-ultrasound fusion guided biopsy. Overall, the course provides an evidence-based and practical overview of methods to detect and diagnose prostate cancer.